Mats Gunnar Pettersson

Director/Board Member presso MAGLE CHEMOSWED HOLDING AB

78 anni

Health Technology

Commercial Services

Distribution Services

Relazioni attive

Nome	Sesso	Età	Società collegate	Collaborazione
Hans Henrik Lidgard	M	78	MAGLE CHEMOSWED HOLDING AB Magle AB Magle AB Chemicals: Major DiversifiedProcess Industries Part of Maria Magle Holding AB, Magle AB is a Swedish company that manufactures chemical products. The private company is based in Lund, Sweden. Magle Chemoswed AB Magle Chemoswed AB Medical SpecialtiesHealth Technology Part of Maria Magle Holding AB, Magle Chemoswed AB is a Swedish company that designs and develops microspheres medical devices. The private company is based in Lund, Sweden.	30 anni
Sven-Christer Nilsson	M	79	MAGLE CHEMOSWED HOLDING AB Magle Chemoswed AB Magle Chemoswed AB Medical SpecialtiesHealth Technology Part of Maria Magle Holding AB, Magle Chemoswed AB is a Swedish company that designs and develops microspheres medical devices. The private company is based in Lund, Sweden.	8 anni
Justin Pierce	M	51	MAGLE CHEMOSWED HOLDING AB Magle AB Magle AB Chemicals: Major DiversifiedProcess Industries Part of Maria Magle Holding AB, Magle AB is a Swedish company that manufactures chemical products. The private company is based in Lund, Sweden. Magle Chemoswed AB Magle Chemoswed AB Medical SpecialtiesHealth Technology Part of Maria Magle Holding AB, Magle Chemoswed AB is a Swedish company that designs and develops microspheres medical devices. The private company is based in Lund, Sweden.	9 anni
Lars Søren Rasmussen	M	65	H. LUNDBECK A/S	11 anni
Erik Dahl	M	-	PHOTOCURE ASA	12 anni
Deirdre Connelly	F	63	GENMAB A/S	7 anni
Rolf K. Hoffmann	M	63	GENMAB A/S	8 anni
Marisol Peron	F	-	GENMAB A/S	5 anni
Pernille Erenbjerg	F	57	GENMAB A/S	9 anni
Paolo Augusto Paoletti	M	73	GENMAB A/S	9 anni
Tahamtan Ahmadi	M	51	GENMAB A/S	7 anni
Martin Lidgard	M	47	MAGLE CHEMOSWED HOLDING AB	3 anni
Ingela Fritzon	M	60	MAGLE CHEMOSWED HOLDING AB	5 anni
Malin Malmsjö	M	51	MAGLE CHEMOSWED HOLDING AB	8 anni
Fredrik Andersson	M	48	MAGLE CHEMOSWED HOLDING AB	25 anni
Petra Sjölin	F	-	MAGLE CHEMOSWED HOLDING AB	4 anni
Helena Ossmer Thedius	M	48	MAGLE CHEMOSWED HOLDING AB	2 anni
Anthony Mancini	M	53	GENMAB A/S	4 anni
Mijke Zachariasse	M	51	GENMAB A/S	5 anni
Mark Beveridge	M	46	MOBERG PHARMA AB	9 anni
Simon Jegou	M	-	MAGLE CHEMOSWED HOLDING AB	2 anni
Judith Klimovsky	M	67	GENMAB A/S	7 anni
Joel Magnus Eklund	M	44	MAGLE CHEMOSWED HOLDING AB	4 anni
Andrew Carlsen	M	-	GENMAB A/S	5 anni
Claudia Lindwall	F	61	MAGLE CHEMOSWED HOLDING AB	3 anni

Mostra altro

Grafico relazionale

Relazione in diverse aziende

Relazioni precedenti

Nome	Sesso	Età	Società collegate	Collaborazione
Geert Cauwenbergh	M	70	MOBERG PHARMA AB ABLYNX	12 anni
Sven Håkan Björklund	M	68	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. H. LUNDBECK A/S	12 anni
Alf Gunnar Martin Nicklasson	M	69	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. SWEDISH ORPHAN BIOVITRUM AB	3 anni
Thomas Lennart Eklund	M	57	MOBERG PHARMA AB	4 anni
Carl Johan Kördel	M	62	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden.	6 anni
Hans Henrik Munch-Jensen	M	64	GENMAB A/S H. LUNDBECK A/S	17 anni
Christian Fekete	M	63	PHOTOCURE ASA	7 anni
Russell Greig	M	71	ABLYNX	-
Wenche Nelly A. Rolfsen Sandsborg	M	72	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. SWEDISH ORPHAN BIOVITRUM AB	8 anni
Anders Götzsche	M	56	H. LUNDBECK A/S	15 anni
Peter Henrik Kürstein-Jensen	M	68	H. LUNDBECK A/S	11 anni
Andreas Eggert	M	56	H. LUNDBECK A/S	5 anni
Mattias Klintemar	M	57	MOBERG PHARMA AB	-
Ulf Arne Wiinberg	M	66	H. LUNDBECK A/S	6 anni
Bo-Gunnar Rosenbrand	M	61	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. SWEDISH ORPHAN BIOVITRUM AB	9 anni
Catarina Larsson	F	72	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden. SWEDISH ORPHAN BIOVITRUM AB	9 anni
Synne Hermansen Røine	F	45	PHOTOCURE ASA	6 anni
Daniel John Bruno	M	45	GENMAB A/S	-
Jonathan Peacock	M	66	GENMAB A/S	1 anni
Lena Nyström	F	68	SWEDISH ORPHAN BIOVITRUM AB	-
Jens Peter Balling	M	-	H. LUNDBECK A/S	-
Thomas Bjerregaard Thomsen	M	54	MOBERG PHARMA AB	4 anni
Anders Edvell	M	55	SWEDISH ORPHAN BIOVITRUM AB	-
Sylvain Forget	M	58	SWEDISH ORPHAN BIOVITRUM AB	-
Rachel Curtis Gravesen	F	55	GENMAB A/S	8 anni
Roger Perlmutter	M	71	ABLYNX	1 anni
Kathleen Deardorff	M	65	PHOTOCURE ASA	5 anni
Xavier Yon	M	84	PHOTOCURE ASA	-
Burt Malkiel	M	90	GENMAB A/S	11 anni
Hans Lennart Rudolf Wigzell	M	86	SWEDISH ORPHAN BIOVITRUM AB	-
Claus Tycho Bræstrup	M	79	H. LUNDBECK A/S	10 anni
Torbjörn Wärnheim	M	66	MOBERG PHARMA AB	7 anni
Eva Steiness	M	83	PHOTOCURE ASA	-
Melanie Lee	M	65	H. LUNDBECK A/S	3 anni
Tom Edward Pike	M	64	PHOTOCURE ASA	6 anni
Remi Vermeiren	M	84	ABLYNX	-
Bente-Lill Romøren	F	75	PHOTOCURE ASA	-
Cecilia Förberg	M	68	SWEDISH ORPHAN BIOVITRUM AB	-
Rima Bawarsh Nassar	M	70	GENMAB A/S	-
Jes Trygved	M	51	H. LUNDBECK A/S	3 anni
Suba Krishnan	M	59	GENMAB A/S	1 anni
Kristian Sibilitz	M	-	H. LUNDBECK A/S	-
Jan Miller	M	54	H. LUNDBECK A/S	11 anni
Henrik Sindal Jensen	M	55	H. LUNDBECK A/S	-
Iman Barilero	M	-	H. LUNDBECK A/S	-
An van Es-Johansson	M	64	SWEDISH ORPHAN BIOVITRUM AB	13 anni
Tugba Ceylan	F	-	H. LUNDBECK A/S	1 anni
João Carlos Nunes Rocha	M	66	H. LUNDBECK A/S	-
Steen Lisby	M	60	GENMAB A/S	9 anni
Barbara Jaszewski	F	65	H. LUNDBECK A/S	-
Ken Friis	M	63	H. LUNDBECK A/S	5 anni
Peter Storm Kristensen	M	49	GENMAB A/S	-
Teddy Hebo Larsen	M	71	H. LUNDBECK A/S	4 anni
Paul W. H. I. Parren	M	60	GENMAB A/S	16 anni
Markus Thor	M	53	Biovitrum AB Biovitrum AB Miscellaneous Commercial ServicesCommercial Services Biovitrum AB develops and sells specialist pharmaceuticals that improve people's lives. The company's business goal is to create a pharmaceutical company with long-term profitability through the international launch and sale of in-house developed products. Research expertise and capabilities are focused on development and production of biotechnology therapeutics within the prioritized areas of hemophilia, inflammation/autoimmune diseases, cancer supportive care and malabsorption. The company was founded in January 2001 and is headquartered in Stockholm, Sweden.	8 anni
Stig Lökke Pedersen	M	62	H. LUNDBECK A/S	19 anni
Michael Steinmetz	M	75	SWEDISH ORPHAN BIOVITRUM AB	10 anni
Christian Peter Dyvig	M	59	H. LUNDBECK A/S	4 anni
Göran Arvidson	M	64	SWEDISH ORPHAN BIOVITRUM AB	16 anni
Fredrik Berg	M	69	SWEDISH ORPHAN BIOVITRUM AB	-
Håkan Åström	M	77	SWEDISH ORPHAN BIOVITRUM AB	9 anni
Jes Christian Wibroe Østergaard	M	76	H. LUNDBECK A/S	-
George Aitken-Davies	M	46	MOBERG PHARMA AB	2 anni
Thorleif Krarup	M	71	H. LUNDBECK A/S	11 anni
Flemming Bent Lindeløv	M	75	H. LUNDBECK A/S	-
Inge Holm Lauritzen	F	57	H. LUNDBECK A/S	9 anni
Peter E. Anastasiou	M	54	H. LUNDBECK A/S	12 anni
Maria Berggren	F	63	SWEDISH ORPHAN BIOVITRUM AB	-
Egil Bodd	M	69	H. LUNDBECK A/S	-
Jørgen Buus Lassen	M	90	NsGene A/S NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark.	9 anni
Kjell-Erik Nordby	M	67	PHOTOCURE ASA	2 anni
Helle Størum	F	57	H. LUNDBECK A/S	9 anni
Klaus Bæk Simonsen	M	-	H. LUNDBECK A/S	-
Maj-Britt Kaltoft	M	61	H. LUNDBECK A/S	5 anni
Niels Svenstrup	M	54	H. LUNDBECK A/S	7 anni

Statistiche

Paese	Relazioni	% del totale
Danimarca	52	52.00%
Svezia	37	37.00%
Norvegia	9	9.00%
Belgio	4	4.00%

Età delle relazioni

Attive

Scorse

Uomo

Donna

Amministratori

Dirigenti

Provenienza delle relazioni